Access
Costs and patients' ability to access PM therapies are a primary concern among PAGs. Practical treatment guidelines and care pathways are also needed to successfully enable broad patient access to PM therapies and diagnostics.
- Early Adoption Policies Necessary to Improve Access
- Need for Making Patient Access a Priority
- Patient Groups Not Confident That Patient Access Will Improve
- Access to Personalized Therapies Is Lagging
- Implementation a Challenge for Patients & Public
- Implementation a Challenge for Healthcare Community
Early Adoption Policies Necessary to Improve Access
While patient groups surveyed strongly agree that healthcare authorities in their respective countries should implement policies to improve early adoption of personalized medicine…
Need for Making Patient Access a Priority
…Patient groups surveyed also think healthcare authorities in their respective countries do not make patient access to innovative cancer treatments a priority…
Patient Groups Not Confident That Patient Access Will Improve
…And patient groups surveyed are not confident healthcare authorities in their respective countries will ensure patient access to new personalized medicines
Access to Personalized Therapies Is Lagging
Patient groups surveyed generally agree that patients in their countries have access to diagnostic tests, but access to personalized therapies lags behind
Implementation a Challenge for Patients & Public
Patient groups surveyed identify affordability of treatments, communication with doctors, and locating treatment centers as key challenges for patients and the public in adopting new personalized medicines
Implementation a Challenge for Healthcare Community
Patient groups surveyed see developing practical treatment guidelines and instituting screening and diagnostic procedures as key challenges confronting the healthcare community in the adoption of new personalized medicines
